Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-21-005458
Filing Date
2021-08-19
Accepted
2021-08-19 17:09:00
Documents
1
Period of Report
2021-08-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 4101
  Complete submission text file 0001562180-21-005458.txt   5403
Mailing Address 3200 WALNUT ST BOULDER CO 80301
Business Address
KOCH KEVIN (Reporting) CIK: 0001185829 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40236 | Film No.: 211190994

Mailing Address 3415 COLORADO AVE. BOULDER CO 80303
Business Address 3415 COLORADO AVE. BOULDER CO 80303 303-735-8373
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations